Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for socio-communicative difficulties in children with and without autism spectrum disorders
2018-000769-35Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of oxytocin in Autism Spectrum Disorder (ASD), sponsored by UZ Leuven. Started Jun 2018; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on 2018-000769-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000769-35.